Tumor immunology has changed the landscape of cancer treatment. Yet, not all patients benefit as cancer immune responsiveness (CIR) remains a limitation in a considerable proportion of cases. The multifactorial determinants of CIR include the genetic makeup of the patient, the genomic instability ce...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!